Form 4: Marchex CFO Nagle Receives Significant Equity Grant

Marchex Chief Financial Officer Brian Nagle was awarded 125,000 Restricted Stock Units and 125,000 stock options, effective October 16, 2025, as part of his compensation.

Summary

• Brian Nagle, Chief Financial Officer of Marchex Inc. (MCHX), was granted equity awards.
• The awards consist of 125,000 Restricted Stock Units (RSUs) and 125,000 Employee Stock Options.
• The grant date for both awards is October 16, 2025.
• Restricted Stock Units (RSUs) vest in full on the fourth anniversary of the grant date.
• Employee Stock Options have an exercise price of $1.81 and vest 25% on the first anniversary of the grant date, with the remainder vesting quarterly over the subsequent three years in 6.25% increments.
• Employee Stock Options expire on October 16, 2035.
• Following these transactions, Brian Nagle beneficially owns 125,000 Restricted Stock Units and 125,000 Employee Stock Options directly.

Sentiment

Score: 7

Explanation: The filing indicates a positive move for executive retention and alignment of interests, as the CFO receives significant equity awards with long-term vesting schedules. This incentivizes the executive to contribute to the company's sustained growth and shareholder value.

Positives

• Aligns the Chief Financial Officer's interests with long-term shareholder value through multi-year vesting schedules.
• Serves as a retention mechanism for key executive talent.
• Represents a standard practice in executive compensation, indicating a structured approach to incentivizing management.

Negatives

• Potential for future share dilution upon vesting and exercise of the equity awards, though this is a common aspect of equity compensation.

Risks

• The value of the equity awards is subject to the future performance of Marchex Inc.'s stock price.
• Market volatility could impact the realized value of the Restricted Stock Units and stock options.

Future Outlook

The equity grants to the Chief Financial Officer suggest a long-term commitment to the company's strategic objectives and aim to incentivize sustained performance over several years, aligning executive interests with future shareholder returns.

Industry Context

The granting of Restricted Stock Units and stock options to a Chief Financial Officer is a common practice across various industries, particularly in technology and growth-oriented companies, to attract, retain, and motivate key executives. This aligns with broader industry trends of performance-based compensation.

Comparison to Industry Standards

• The use of both Restricted Stock Units (RSUs) and stock options is a standard dual-pronged approach in executive compensation packages, similar to practices observed at comparable companies in the software and digital advertising sectors.
• The four-year vesting schedule for both RSUs and stock options is typical for executive equity awards, designed to promote long-term retention and performance, consistent with benchmarks in the technology industry.
• The exercise price of $1.81 for the stock options, likely at or above the market price on the grant date, is a common feature of incentive stock options, requiring stock price appreciation for value realization, similar to grants at companies like LiveRamp or Verint Systems.

Stakeholder Impact

• Shareholders: Potential for minor future dilution from the issuance of shares upon vesting and exercise, but also benefit from increased executive incentive for long-term performance.
• Employees: Signals continued commitment from a key executive, potentially boosting morale and stability.

Next Steps

• Vesting of 25% of stock options on October 16, 2026.
• Subsequent quarterly vesting of stock options over the next three years.
• Full vesting of Restricted Stock Units on October 16, 2029.

Key Dates

Keywords

Marchex, MCHX, Brian Nagle, CFO, Form 4, Restricted Stock Units, RSU, Stock Options, Equity Compensation, Executive Compensation, Insider Transaction